Cyclica is pleased to announce the appointment of Dr. Rick Panicucci to its Scientific Advisory Board. Rick is the current Vice President of Pharmaceutical Development and Business Development at WuXi AppTec where his responsibilities include providing leadership in the areas of Developability, Formulation Development, and GMP Manufacturing. Prior to WuXi he held the position of Global Head of Chemical and Pharmaceutical Profiling (CPP) at Novartis from 2004 to 2015. Where he led the development and implementation of innovative dosage form designs and continuous manufacturing paradigms. He worked closely with Novartis BD&L and Venture Fund on many external deals such as Proteus Digital Health, MicroChips, 7th Sense Bio, West Pharma, Unilife, MIT and University of Toronto to mention a few.
Dr. Panicucci currently holds the position of Adjunct Professor at Massachusetts College of Pharmacy. His education includes two post-doctoral fellowships at University of California at Santa Barbara and the Ontario Cancer Institute. Dr. Panicucci received his Ph.D. in Physical Organic Chemistry from the University of Toronto.
Dr. Panicucci will use his expansive expertise in the Pharmaceutical space to guide Cyclica's growth and development.